title: [Peritoneal tuberculosis as a complication in a case of unclassifiable myelodysplastic/myeloproliferative disease].
abstract: We report the case of a 68-year-old male with a diagnosis of unclassifiable myelodysplatic/myeloproliferative disease (WHO classification), under prolonged steroid treatment and unsuccesful chemotherapy response, who developed progressive asthenia, thoracic pain, minimal efforts dyspnea, and abdominal distension, that initially was suspicious of splenic rupture. Exploratory laparotomy showed multiple peritoneal implants, and a diagnosis of peritoneal tuberculosis was obtained from local biopsy. Definitive diagnosis included a positive result to culture and PCR urine test, together with a possible pleural and splenic tuberculous affectation. Response to tuberculostatic treatment was successful. To the best of our knowledge, this is the first reported case with such characteristics.
authors.affiliation: Servicio de Hematología y Hemoterapia, Hospital Universitario de Canarias, La Laguna, Tenerife. taidamar@hotmail.com
authors.forename: T
authors.initials: T
authors.lastname: Martín Santos
authors.forename: L
authors.initials: L
authors.lastname: Morabito
authors.forename: J M
authors.initials: JM
authors.lastname: Raya Sánchez
authors.forename: M M
authors.initials: MM
authors.lastname: Alonso Socas
authors.forename: B
authors.initials: B
authors.lastname: González González
authors.forename: M T
authors.initials: MT
authors.lastname: Hernández García
authors.forename: L
authors.initials: L
authors.lastname: Hernández Nieto
mesh_terms: D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use; D001706:Biopsy; D006801:Humans; D008297:Male; D054437:Myelodysplastic-Myeloproliferative Diseases / Q000145:classification / Q000150:complications*; D010537:Peritoneum / Q000473:pathology; D014395:Peritonitis, Tuberculous / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D016896:Treatment Outcome; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents